[
1. Somberg JS, Molnar J. Usefulness of QT dispersion as an electrocardiographically derived index. Am J Cardiol. 2002;89:291-294. doi: 10.1016/s0002-9149(01)02230-5.10.1016/S0002-9149(01)02230-5
]Search in Google Scholar
[
2. Yu Z, Chen Z, Wu Y, et al. Electrocardiographic parameters effectively predict ventricular tachycardia/fibrillation in acute phase and abnormal cardiac function in chronic phase of ST-segment elevation myocardial infarction. J Cardiovasc Electrophysiol. 2018;29:756-766. doi: 10.1111/jce.13453.10.1111/jce.13453
]Search in Google Scholar
[
3. Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol. 2000;36:1749-1766. doi: 10.1016/s0735-1097(00)00962-1.10.1016/S0735-1097(00)00962-1
]Search in Google Scholar
[
4. Kanbay M, Solak Y, Dogan E, et al. Uric Acid in Hypertension and Renal Disease: The Chicken or the Egg. Blood Purif. 2010;30:288-295. doi: 10.1159/000321074.10.1159/000321074
]Search in Google Scholar
[
5. Ahmadnezhad M, Arefhosseini SR, Parizadeh MR, et al. Association between serum uric acid, high sensitive C-reactive protein and pro-oxidant-antioxidant balance in patients with metabolic syndrome. Biofactors. 2018;44:263-271. doi: 10.1002/biof.1424.10.1002/biof.1424
]Search in Google Scholar
[
6. Grayson PC, Kim SY, LaValley M, et al. Hyperuricemia and incident hypertension: A systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63:102-110. doi: 10.1002/acr.20344.10.1002/acr.20344
]Search in Google Scholar
[
7. Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and risk of stroke: A systematic review and meta-analysis. Arthritis and Rheumatism. 2009;61:885-892. doi: 10.1002/art.24612.10.1002/art.24612
]Search in Google Scholar
[
8. Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010;62:170-180. doi: 10.1002/acr.20065.10.1002/acr.20065
]Search in Google Scholar
[
9. Kodama S, Saito K, Yachi Y, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32:1737-1742. doi: 10.2337/dc09-0288.10.2337/dc09-0288
]Search in Google Scholar
[
10. Zhang JX, Lin X, Xu J, et al. Hyperuricemia Inhibition Protects SD Rats Against Fructose-Induced Obesity Hypertension Via Modulation of Inflammation and Renin-Angiotensin System in Adipose Tissue. Exp Clin Endocrinol Diabetes. 2021;129:314-321. doi: 10.1055/a-1023-6710.10.1055/a-1023-6710
]Search in Google Scholar
[
11. Krishnan E, Sokolove J. Uric acid in heart disease: a new C-reactive protein? Curr Opin Rheumatol. 2011;23:174-177. doi: 10.1097/BOR.0b013e3283432dd3.10.1097/BOR.0b013e3283432dd3
]Search in Google Scholar
[
12. Straus SM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47:362-367. doi: 10.1016/j.jacc.2005.08.067.10.1016/j.jacc.2005.08.067
]Search in Google Scholar
[
13. Ryerson LM, Giuffre RM. QT intervals in metabolic dilated cardiomyopathy. Can J Cardiol. 2006;22:217-220. doi: 10.1016/s0828-282x(06)70899-6.10.1016/S0828-282X(06)70899-6
]Search in Google Scholar
[
14. Elming H, Holm E, Jun L, et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J. 1998;19:1391-1400. doi: 10.1053/euhj.1998.1094.10.1053/euhj.1998.1094
]Search in Google Scholar
[
15. Cuddy TE, Halli PS, Tate RB. QT dispersion and heart rate predict the risk of sudden unexpected cardiac death in men: the Manitoba Follow-Up Study. Prev Cardiol. 2009;12:27-33. doi: 10.1111/j.1751-7141.2008.00016.x.10.1111/j.1751-7141.2008.00016.x
]Search in Google Scholar
[
16. Bazoukis G, Yeung C, Wui Hang Ho R, et al. Association of QT dispersion with mortality and arrhythmic events-A meta-analysis of observational studies. J Arrhythm. 2019;36:105-115. doi: 10.1002/joa3.12253.10.1002/joa3.12253
]Search in Google Scholar
[
17. Brooksby P, Robinson PJ, Segal R, et al. Effects of losartan and captopril on QT dispersion in elderly patients with heart failure. ELITE study group. Lancet. 1999;534:395-396. doi: 10.1016/s0140-6736(99)01354-9.10.1016/S0140-6736(99)01354-9
]Search in Google Scholar
[
18. Uchiyama K, Hayashi K, Fujino N, et al. Impact of QT variables on clinical outcome of genotyped hypertrophic cardiomyopathy. Ann Noninvasive Electrocardiol. 2009;14:65-71. doi: 10.1111/j.1542-474X.2008.00275.x.10.1111/j.1542-474X.2008.00275.x
]Search in Google Scholar
[
19. Gertler MM, Garn SM, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med. 1951;34:1421-1431. doi: 10.7326/0003-4819-34-6-1421.10.7326/0003-4819-34-6-1421
]Search in Google Scholar
[
20. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 2000;283:2404-2410. doi: 10.1001/jama.283.18.2404.10.1001/jama.283.18.2404
]Search in Google Scholar
[
21. Puddu PE, Lanti M, Menotti A, et al. Gubbio Study Research Group. Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population study. Acta Cardiol. 2001;56:243-251. doi: 10.2143/AC.56.4.2005651.10.2143/AC.56.4.2005651
]Search in Google Scholar
[
22. Franse LV, Pahor M, Di Bari M, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens. 2000;18:1149-1154. doi: 10.1097/00004872-200018080-00021.10.1097/00004872-200018080-00021
]Search in Google Scholar
[
23. Egas-Izquierdo M, Wong-Achi X, Alvarado-Villa G, et al. Relation between serum uric acid levels with the degree of coronary artery disease: A prospective study from Ecuador. Clin Investig Arterioscler. 2019;31:8-14. doi: 10.1016/j.arteri.2018.09.001.10.1016/j.arteri.2018.09.001
]Search in Google Scholar
[
24. Kanbay M, Ikizek M, Solak Y, et al. Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease. Am J Nephrol. 2011;33:325-331. doi: 10.1159/000324916.10.1159/000324916
]Search in Google Scholar
[
25. Moriarity JT, Folsom AR, Iribarren C, et al. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol. 2000;10:136-143. doi: 10.1016/s1047-2797(99)00037-x.10.1016/S1047-2797(99)00037-X
]Search in Google Scholar
[
26. Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131:7-13. doi: 10.7326/0003-4819-131-1-199907060-00003.10.7326/0003-4819-131-1-199907060-00003
]Search in Google Scholar
[
27. Wannamethee SG. Serum uric acid is not an independent risk factor for coronary heart disease. Curr Hypertens Rep. 2001;3:190-196. doi: 10.1007/s11906-001-0037-3.10.1007/s11906-001-0037-3
]Search in Google Scholar
[
28. Sakata K, Hashimoto T, Ueshima H, et al. Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. Eur J Epidemiol. 2001;17:461-468. doi: 10.1023/a:1013735717961.10.1023/A:1013735717961
]Search in Google Scholar
[
29. Naghavi M, John R, Naguib S, et al. pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque. Atherosclerosis. 2002;164:27-35. doi: 10.1016/s0021-9150(02)00018-7.10.1016/S0021-9150(02)00018-7
]Search in Google Scholar
[
30. Hare JM, Johnson RJ. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation. 2003;107:1951-1953. doi: 10.1161/01.CIR.0000066420.36123.35.10.1161/01.CIR.0000066420.36123.35
]Search in Google Scholar
[
31. Cappola TP, Kass DA, Nelson GS, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation. 2001;104:2407-2411. doi: 10.1161/hc4501.098928.10.1161/hc4501.098928
]Search in Google Scholar
[
32. Farquharson CAJ, Butler R, Hill A, et al. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation. 2002;106:221-226. doi: 10.1161/01.cir.0000022140.61460.1d.10.1161/01.CIR.0000022140.61460.1D
]Search in Google Scholar
[
33. Doehner W, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation. 2002;105:2619-2624. doi: 10.1161/01.cir.0000017502.58595.ed.10.1161/01.CIR.0000017502.58595.ED
]Search in Google Scholar
[
34. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67:1739-1742. doi: 10.1111/j.1523-1755.2005.00273.x.10.1111/j.1523-1755.2005.00273.x
]Search in Google Scholar
[
35. Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol. 2002;282:F991-997. doi: 10.1152/ajprenal.00283.2001.10.1152/ajprenal.00283.2001
]Search in Google Scholar
[
36. Mazalli M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001;38:1101-1106. doi: 10.1161/hy1101.092839.10.1161/hy1101.092839
]Search in Google Scholar
[
37. Waring WS, Adwani SH, Breukels O, et al. Hyperuricaemia does not impair cardiovascular function in healthy adults. Heart. 2004;90:155-159. doi: 10.1136/hrt.2003.016121.10.1136/hrt.2003.016121
]Search in Google Scholar
[
38. Chamorro A, Planas AM. Yin and yang of uric acid in patients with stroke. Stroke. 2004;35:e11-e12. doi: 10.1161/01.STR.0000107762.79571.7D.10.1161/01.STR.0000107762.79571.7D
]Search in Google Scholar
[
39. Cicero AF, Rosticci M, Tocci G, et al. Serum uric acid and other short-term predictors of electrocardiographic alterations in the Brisighella Heart Study cohort. Eur J Intern Med. 2015;26:255-258. doi: 10.1016/j.ejim.2015.02.007.10.1016/j.ejim.2015.02.007
]Search in Google Scholar
[
40. Özyılmaz S, Satılmışoğlu MH, Gül M, et al. Evaluation of the association between serum uric acid level and the predicted risk score of sudden cardiac death in five years in patients with hypertrophic cardiomyopathy. Turk Kardiyol Dern Ars. 2018;46:111-120. doi: 10.5543/tkda.2017.60094.10.5543/tkda.2017.60094
]Search in Google Scholar
[
41. Nodera M, Suzuki H, Matsumoto Y, et al. Association between Serum Uric Acid Level and Ventricular Tachyarrhythmia in Heart Failure Patients with Implantable Cardioverter-Defibrillator. Cardiology. 2018;140:47-51. doi: 10.1159/000488851.10.1159/000488851
]Search in Google Scholar
[
42. Yamada S, Suzuki H, Kamioka M, et al. Uric acid increases the incidence of ventricular arrhythmia in patients with left ventricular hypertrophy. Fukushima J Med Sci. 2012;58:101-106. doi: 10.5387/fms.58.101.10.5387/fms.58.101
]Search in Google Scholar
